Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region AMMAN, Jordan and RIYADH, Saudi Arabia, May 18, 2026 /CNW/ -- MS Pharma today announced that Olayan Financing ...
Kashiv BioSciences and MS Pharma have entered into a license and supply agreement for ADL-018, Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the Middle ...
AMMAN, Jordan and RIYADH, Saudi Arabia, May 18, 2026 /PRNewswire/ -- MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This ...
MS Pharma, a leading regional pharmaceutical company in the MENA region, announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This partnership brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results